10-Q Filing

GUARDANT HEALTH, INC. CIK: 1576280 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001576280-22-000092`
Period End Date	20220930
Filing Date	20221103
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	gh-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 96 Cash Flow Statement 101 Stockholders Equity 42 Comprehensive Income 28

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$158.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$492.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$832.37M	USD	Point-in-time
Short-term marketable debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$799.73M	USD	Point-in-time
Short-term marketable debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$440.55M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$97.65M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$86.20M	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Inventory, net	`InventoryNet`	$63.05M	USD	Point-in-time
Inventory, net	`InventoryNet`	$30.67M	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$23.57M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$53.05M	USD	Point-in-time
Preferred stock issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.13B	USD	Point-in-time
Preferred stock issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.11B	USD	Point-in-time
Preferred stock outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Long-term marketable debt securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$698.03M	USD	Point-in-time
Preferred stock outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Long-term marketable debt securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$156.74M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$124.46M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$168.01M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$178.75M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$189.44M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	102.41M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	101.77M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$14.21M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$12.42M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	102.41M	shares	Point-in-time
Goodwill	`Goodwill`	$3.29M	USD	Point-in-time
Goodwill	`Goodwill`	$3.29M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	101.77M	shares	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$60.94M	USD	Point-in-time
Assets	`Assets`	$2.20B	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$51.73M	USD	Point-in-time
Assets	`Assets`	$1.70B	USD	Point-in-time
Total Assets	`Assets`	$2.20B	USD	Point-in-time
Liabilities	`Liabilities`	$1.56B	USD	Point-in-time
Liabilities	`Liabilities`	$1.54B	USD	Point-in-time
Total Assets	`Assets`	$1.70B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$40.91M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.58M	USD	Point-in-time
Accrued compensation	`DeferredCompensationLiabilityCurrent`	$42.50M	USD	Point-in-time
Accrued compensation	`DeferredCompensationLiabilityCurrent`	$57.42M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$45.28M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$63.37M	USD	Point-in-time
Noncontrolling interest liability	`InvestmentsPayable`	-	USD	Point-in-time
Noncontrolling interest liability	`InvestmentsPayable`	$78.00M	USD	Point-in-time
Noncontrolling interest liability	`InvestmentsPayable`	$78.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$11.33M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$13.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$175.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$194.69M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$1.14B	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$1.13B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$226.05M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$216.17M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.99M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$3.93M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.56B	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.54B	USD	Point-in-time
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2022 and December 31, 2021	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2022 and December 31, 2021	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of September 30, 2022, and December 31, 2021; 102,413,638 and 101,767,446 shares issued and outstanding as of September 30, 2022, and December 31, 2021, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of September 30, 2022, and December 31, 2021; 102,413,638 and 101,767,446 shares issued and outstanding as of September 30, 2022, and December 31, 2021, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.72B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.66B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.76M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-26.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.52B	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$166.75M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$709.42M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$645.00M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$788.07M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$1.30B	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$319.09M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.70B	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$2.20B	USD	Point-in-time

Income Statement 96 line items

Line Item	Tag	Value	Unit	Period
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$102.05M	USD	1 Quarter
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$79.27M	USD	1 Quarter
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$278.25M	USD	3 Qtrs
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$215.60M	USD	3 Qtrs
Development services and other	`RevenueFromDevelopmentServices`	$49.94M	USD	3 Qtrs
Development services and other	`RevenueFromDevelopmentServices`	$15.51M	USD	1 Quarter
Development services and other	`RevenueFromDevelopmentServices`	$15.35M	USD	1 Quarter
Development services and other	`RevenueFromDevelopmentServices`	$44.40M	USD	3 Qtrs
Total revenue	`Revenues`	$94.78M	USD	1 Quarter
Total revenue	`Revenues`	$117.40M	USD	1 Quarter
Total revenue	`Revenues`	$265.55M	USD	3 Qtrs
Total revenue	`Revenues`	$322.65M	USD	3 Qtrs
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$39.43M	USD	1 Quarter
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$104.49M	USD	3 Qtrs
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$78.14M	USD	3 Qtrs
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$29.66M	USD	1 Quarter
Cost of development services and other	`CostOfDevelopmentServices`	$1.15M	USD	1 Quarter
Cost of development services and other	`CostOfDevelopmentServices`	$11.35M	USD	3 Qtrs
Cost of development services and other	`CostOfDevelopmentServices`	$4.71M	USD	3 Qtrs
Cost of development services and other	`CostOfDevelopmentServices`	$1.06M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$267.23M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$100.02M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$70.97M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$190.20M	USD	3 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$50.23M	USD	1 Quarter
Sales and marketing expense	`SellingAndMarketingExpense`	$132.28M	USD	3 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$218.41M	USD	3 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$80.37M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$126.07M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$50.05M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$166.37M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$41.12M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$578.34M	USD	3 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$202.07M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$720.91M	USD	3 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$262.00M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-144.60M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-398.26M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-312.79M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-107.29M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.28M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$3.92M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.75M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$689.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$644.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.93M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.93M	USD	3 Qtrs
Interest expense	`InterestExpense`	$644.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-18.06M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-720.00K	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-18.39M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-187.00K	USD	1 Quarter
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	-	USD	3 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	$-99.78M	USD	3 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	-	USD	1 Quarter
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	-	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-312.17M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-107.43M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-161.88M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-514.12M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$96.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$115.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$537.00K	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$289.00K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-161.99M	USD	1 Quarter
Net loss	`ProfitLoss`	$-107.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-514.65M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-312.46M	USD	3 Qtrs
Adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	-	USD	3 Qtrs
Adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	-	USD	1 Quarter
Adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	$2.30M	USD	3 Qtrs
Adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-107.53M	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-514.65M	USD	3 Qtrs
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-161.99M	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-314.76M	USD	3 Qtrs
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-107.53M	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-161.99M	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-514.65M	USD	3 Qtrs
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-314.76M	USD	3 Qtrs
Net loss per share attributable to Guardant Health, Inc. common stockholders, basic (in usd per share)	`EarningsPerShareBasic`	$-1.06	USD	1 Quarter
Net loss per share attributable to Guardant Health, Inc. common stockholders, basic (in usd per share)	`EarningsPerShareBasic`	$-5.04	USD	3 Qtrs
Net loss per share attributable to Guardant Health, Inc. common stockholders, basic (in usd per share)	`EarningsPerShareBasic`	$-1.58	USD	1 Quarter
Net loss per share attributable to Guardant Health, Inc. common stockholders, basic (in usd per share)	`EarningsPerShareBasic`	$-3.11	USD	3 Qtrs
Net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in usd per share)	`EarningsPerShareDiluted`	$-5.04	USD	3 Qtrs
Net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.58	USD	1 Quarter
Net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.06	USD	1 Quarter
Net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in usd per share)	`EarningsPerShareDiluted`	$-3.11	USD	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.06M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.29M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	101.42M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	101.18M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.06M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.42M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.29M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.18M	shares	3 Qtrs

Cash Flow Statement 101 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-161.99M	USD	1 Quarter
Net loss	`ProfitLoss`	$-107.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-514.65M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-312.46M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.79M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$16.18M	USD	3 Qtrs
Non-cash operating lease costs	`NonCashOperatingLeaseCosts`	$17.78M	USD	3 Qtrs
Non-cash operating lease costs	`NonCashOperatingLeaseCosts`	$21.39M	USD	3 Qtrs
Re-valuation of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.84M	USD	3 Qtrs
Re-valuation of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$4.20M	USD	3 Qtrs
Non-cash stock-based compensation	`ShareBasedCompensation`	$70.98M	USD	3 Qtrs
Non-cash stock-based compensation	`ShareBasedCompensation`	$124.59M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.92M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.93M	USD	3 Qtrs
Amortization of premium (discount) on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-9.55M	USD	3 Qtrs
Amortization of premium (discount) on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.37M	USD	3 Qtrs
Unrealized losses on marketable equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-13.23M	USD	3 Qtrs
Unrealized losses on marketable equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	-	USD	3 Qtrs
Impairment of other assets	`OtherAssetImpairmentCharges`	-	USD	3 Qtrs
Impairment of other assets	`OtherAssetImpairmentCharges`	$5.26M	USD	3 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueAdjustmentsOfNoncontrollingInterestLiability`	$-99.78M	USD	3 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueAdjustmentsOfNoncontrollingInterestLiability`	-	USD	3 Qtrs
Other	`OtherNoncashIncomeExpense`	$-23.00K	USD	3 Qtrs
Other	`OtherNoncashIncomeExpense`	$-8.00K	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-11.43M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$7.45M	USD	3 Qtrs
Inventory, net	`IncreaseDecreaseInInventories`	$2.02M	USD	3 Qtrs
Inventory, net	`IncreaseDecreaseInInventories`	$32.38M	USD	3 Qtrs
Prepaid expenses and other current assets, net	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-28.39M	USD	3 Qtrs
Prepaid expenses and other current assets, net	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.76M	USD	3 Qtrs
Other assets, net	`IncreaseDecreaseInOtherOperatingAssets`	$-4.77M	USD	3 Qtrs
Other assets, net	`IncreaseDecreaseInOtherOperatingAssets`	$3.23M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$17.75M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.94M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$14.93M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$10.56M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$14.03M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$10.48M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-12.99M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$258.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-1.23M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$4.05M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-218.71M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-132.03M	USD	3 Qtrs
Purchase of marketable debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$334.08M	USD	3 Qtrs
Purchase of marketable debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$238.60M	USD	3 Qtrs
Maturity of marketable debt securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$627.11M	USD	3 Qtrs
Maturity of marketable debt securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$398.00M	USD	3 Qtrs
Purchase of non-marketable equity securities and other related investments	`PaymentsToAcquireEquitySecuritiesFvNi`	$39.08M	USD	3 Qtrs
Purchase of non-marketable equity securities and other related investments	`PaymentsToAcquireEquitySecuritiesFvNi`	$12.75M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$67.46M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$50.41M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$203.54M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$79.19M	USD	3 Qtrs
Payments made on finance lease obligations	`FinanceLeasePrincipalPayments`	$129.00K	USD	3 Qtrs
Payments made on finance lease obligations	`FinanceLeasePrincipalPayments`	$53.00K	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.50M	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$7.07M	USD	3 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$5.74M	USD	3 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$5.40M	USD	3 Qtrs
Taxes paid related to net share settlement of restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$6.52M	USD	3 Qtrs
Taxes paid related to net share settlement of restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$82.16M	USD	3 Qtrs
Joint Venture Acquisition	`PaymentsForJointVentureAcquisitionFinancingActivities`	-	USD	3 Qtrs
Joint Venture Acquisition	`PaymentsForJointVentureAcquisitionFinancingActivities`	$177.78M	USD	3 Qtrs
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`NoncashTenderOfferIssued`	-	USD	3 Qtrs
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`NoncashTenderOfferIssued`	$-14.24M	USD	3 Qtrs
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	3 Qtrs
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$1.06M	USD	3 Qtrs
Payment of offering costs related to borrowings on convertible senior notes	`PaymentsOfDebtIssuanceCosts`	$784.00K	USD	3 Qtrs
Payment of offering costs related to borrowings on convertible senior notes	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-191.41M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-70.60M	USD	3 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.74M	USD	3 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.19M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-333.68M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-284.00K	USD	3 Qtrs
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$158.61M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$832.69M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$832.98M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$158.61M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$832.69M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$832.98M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time
Operating lease liabilities arising from obtaining right-of-use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$4.07M	USD	3 Qtrs
Operating lease liabilities arising from obtaining right-of-use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$171.07M	USD	3 Qtrs
Purchase of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$8.91M	USD	3 Qtrs
Purchase of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$9.59M	USD	3 Qtrs
Issuance costs related to purchase of non-marketable equity and other related investments included in accounts payable and accrued expenses	`EquitySecuritiesFVNIIncurredButNotYetPaid`	-	USD	3 Qtrs
Issuance costs related to purchase of non-marketable equity and other related investments included in accounts payable and accrued expenses	`EquitySecuritiesFVNIIncurredButNotYetPaid`	$346.00K	USD	3 Qtrs
Property and equipment acquired under finance leases	`PropertyPlantAndEquipmentAcquiredUnderFinanceLeases`	-	USD	3 Qtrs
Property and equipment acquired under finance leases	`PropertyPlantAndEquipmentAcquiredUnderFinanceLeases`	$238.00K	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$158.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$492.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$832.37M	USD	Point-in-time
Restricted cash included in other assets, net	`RestrictedCashNoncurrent`	$323.00K	USD	Point-in-time
Restricted cash included in other assets, net	`RestrictedCashNoncurrent`	$302.00K	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$158.61M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$832.69M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$832.98M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Adjustment of redeemable noncontrolling interest	`ReclassificationsOfTemporaryToPermanentEquity`	$-2.30M	USD	3 Qtrs
Beginning balance	`StockholdersEquity`	$166.75M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$709.42M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$645.00M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$788.07M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.30B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$319.09M	USD	Point-in-time
Issuance of common stock upon exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	207,353.00	shares	3 Qtrs
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$347.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.07M	USD	3 Qtrs
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.68M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.50M	USD	3 Qtrs
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$13.00K	USD	1 Quarter
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$8.00K	USD	3 Qtrs
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$39.00K	USD	3 Qtrs
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$5.40M	USD	3 Qtrs
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$5.74M	USD	3 Qtrs
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$6.52M	USD	3 Qtrs
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$7.20M	USD	1 Quarter
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$4.34M	USD	1 Quarter
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$82.16M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$70.98M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.64M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$124.59M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$35.02M	USD	1 Quarter
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`AdjustmentsToAdditionalPaidInCapitalTenderOfferIssued`	$4.40M	USD	1 Quarter
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`AdjustmentsToAdditionalPaidInCapitalTenderOfferIssued`	$14.23M	USD	3 Qtrs
Adjustment of redeemable noncontrolling interest	`ReclassificationsOfTemporaryToPermanentEquity`	$-2.30M	USD	3 Qtrs
Other comprehensive loss, net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$-626.00K	USD	1 Quarter
Other comprehensive loss, net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$-22.09M	USD	3 Qtrs
Other comprehensive loss, net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$-3.29M	USD	3 Qtrs
Other comprehensive loss, net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$-2.59M	USD	1 Quarter
Net loss	`ProfitLoss`	$-161.99M	USD	1 Quarter
Net loss	`ProfitLoss`	$-107.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-514.65M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-312.46M	USD	3 Qtrs
Ending balance	`StockholdersEquity`	$166.75M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$709.42M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$645.00M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$788.07M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.30B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$319.09M	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-161.99M	USD	1 Quarter
Net loss	`ProfitLoss`	$-107.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-514.65M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-312.46M	USD	3 Qtrs
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-513.00K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-19.35M	USD	3 Qtrs
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.06M	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.10M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-113.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.19M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-529.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-2.74M	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-626.00K	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-22.09M	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-3.29M	USD	3 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-2.59M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-315.75M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-108.15M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-164.59M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-536.74M	USD	3 Qtrs
Comprehensive loss attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$2.30M	USD	3 Qtrs
Comprehensive loss attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive loss attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive loss attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-164.59M	USD	1 Quarter
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-318.05M	USD	3 Qtrs
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-108.15M	USD	1 Quarter
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-536.74M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.